Natco Pharma Ltd – Strategy, SWOT and Corporate Finance Report

Natco Pharma Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome and prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) for the domestic and international markets. It operates API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.

Scope

Detailed information on Natco Pharma Ltd required for business and competitor intelligence needs

A study of the major internal and external factors affecting Natco Pharma Ltd in the form of a SWOT analysis

An in-depth view of the business model of Natco Pharma Ltd including a breakdown and examination of key business segments

News about Natco Pharma Ltd, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Natco Pharma Ltd and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Natco Pharma Ltd as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Natco Pharma Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Suven Life Sciences Ltd

Piramal Enterprises Ltd

Jubilant Life Sciences Ltd

Divi's Laboratories Ltd

Biocon Ltd

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Natco Pharma Ltd - Key Facts 6

Natco Pharma Ltd - Key Employees 7

Natco Pharma Ltd - Key Employee Biographies 9

Natco Pharma Ltd - Major Products and Services 10

Natco Pharma Ltd - History 11

Natco Pharma Ltd - Company Statement 14

Natco Pharma Ltd - Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Joint Venture 17

Section 2 Company Analysis 18

Company Overview 18

Natco Pharma Ltd - Business Description 19

Business Segment: Active Pharmaceutical Ingredients 19

Overview 19

Performance 19

Business Segment: Domestic Formulations 19

Overview 19

Performance 19

Business Segment: International Formulations 20

Overview 20

Performance 20

Business Segment: Others 20

Overview 20

Performance 20

Business Segment: Outside India 20

Capital Expenditure 20

Geographical Segment: India 20

Performance 20

R&D Overview 20

Natco Pharma Ltd - Corporate Strategy 21

Natco Pharma Ltd - SWOT Analysis 22

SWOT Analysis - Overview 22

Natco Pharma Ltd - Strengths 22

Natco Pharma Ltd - Weaknesses 24

Natco Pharma Ltd - Opportunities 25

Natco Pharma Ltd - Threats 26

Natco Pharma Ltd - Key Competitors 27

Section 3 Company Financial Ratios 28

Financial Ratios - Capital Market Ratios 28

Financial Ratios - Annual Ratios 29

Performance Chart 32

Financial Performance 32

Financial Ratios - Interim Ratios 33

Financial Ratios - Ratio Charts 34

Section 4 Company’s Lifesciences Financial Deals and Alliances 35

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 35

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 36

Natco Pharma Ltd, Recent Deals Summary 37

Section 5 Company’s Recent Developments 38

Aug 08, 2018: NATCO records INR

574.5 Crores consolidated revenue and INR

181.1 Crore of profit, after tax, for the First Quarter, FY2018-19 38

May 23, 2018: NATCO records INR 2,242 Crore consolidated revenue and INR 695 Crore of profit, after tax, for the full year ended March 2018 39

Feb 17, 2018: USFDA completes inspection of Natco's Mekaguda API facility with zero observations 40

Feb 06, 2018: NATCO records INR

573.6 Crore revenue and INR

217.4 Crore of Profit, after tax, for the Third Quarter, FY 2017-18 41

Aug 07, 2017: NATCO Pharma Reports Financial Results For The Quarter Ended 30 June 2017 42

Aug 07, 2017: Natco Pharma Announces Resignation of Directors 43

Jul 20, 2017: NATCO receives establishment inspection report (EIR) from U.S. food and drug administration (FDA) 44

May 30, 2017: NATCO records INR

2078.9 Crore total consolidated revenue and INR

486.0 Crore of profit, after tax, for the full year ended March 2017 45

Feb 14, 2017: NATCO records INR

685.13 Crore total consolidated revenue and INR

194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017 46

Jan 25, 2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility 47

Section 6 Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52

List of Tables

List of Tables

Natco Pharma Ltd, Key Facts 6

Natco Pharma Ltd, Key Employees 7

Natco Pharma Ltd, Key Employee Biographies 9

Natco Pharma Ltd, Major Products and Services 10

Natco Pharma Ltd, History 11

Natco Pharma Ltd, Other Locations 16

Natco Pharma Ltd, Subsidiaries 16

Natco Pharma Ltd, Joint Venture 17

Natco Pharma Ltd, Key Competitors 27

Natco Pharma Ltd, Ratios based on current share price 28

Natco Pharma Ltd, Annual Ratios 29

Natco Pharma Ltd, Annual Ratios (Cont…1) 30

Natco Pharma Ltd, Annual Ratios (Cont…2) 31

Natco Pharma Ltd, Interim Ratios 33

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 35

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 36

Natco Pharma Ltd, Recent Deals Summary 37

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

List of Figures

List of Figures

Natco Pharma Ltd, Performance Chart (2014 – 2018) 32

Natco Pharma Ltd, Ratio Charts 34

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 35

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 36

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports